These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8504474)

  • 41. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
    Loehberg CR; Thompson T; Kastan MB; Maclean KH; Edwards DG; Kittrell FS; Medina D; Conneely OM; O'Malley BW
    Cancer Res; 2007 Dec; 67(24):12026-33. PubMed ID: 18089834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation.
    Albor A; Flessate DM; Soussi T; Notario V
    Cancer Res; 1994 Aug; 54(16):4502-7. PubMed ID: 8044802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry.
    Bonsing BA; Corver WE; Gorsira MC; van Vliet M; Oud PS; Cornelisse CJ; Fleuren GJ
    Cytometry; 1997 May; 28(1):11-24. PubMed ID: 9136751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
    Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
    Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reciprocal modifications of CLIC4 in tumor epithelium and stroma mark malignant progression of multiple human cancers.
    Suh KS; Crutchley JM; Koochek A; Ryscavage A; Bhat K; Tanaka T; Oshima A; Fitzgerald P; Yuspa SH
    Clin Cancer Res; 2007 Jan; 13(1):121-31. PubMed ID: 17200346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.
    Reiss M; Brash DE; Muñoz-Antonia T; Simon JA; Ziegler A; Vellucci VF; Zhou ZL
    Oncol Res; 1992; 4(8-9):349-57. PubMed ID: 1486218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53.
    Abarzúa P; LoSardo JE; Gubler ML; Neri A
    Cancer Res; 1995 Aug; 55(16):3490-4. PubMed ID: 7627952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased p53 protein associated with aging in human diploid fibroblasts.
    Kulju KS; Lehman JM
    Exp Cell Res; 1995 Apr; 217(2):336-45. PubMed ID: 7698234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the p53 tumour suppressor gene product is a determinant of chemosensitivity.
    Petty RD; Cree IA; Sutherland LA; Hunter EM; Lane DP; Preece PE; Andreotti PE
    Biochem Biophys Res Commun; 1994 Feb; 199(1):264-70. PubMed ID: 8123022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of cell cycle, wild-type p53 and DNA damage on p21CIP1/Waf1 expression in human breast epithelial cells.
    Gudas J; Nguyen H; Li T; Hill D; Cowan KH
    Oncogene; 1995 Jul; 11(2):253-61. PubMed ID: 7624142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maintenance of p53 alterations throughout breast cancer progression.
    Davidoff AM; Kerns BJ; Iglehart JD; Marks JR
    Cancer Res; 1991 May; 51(10):2605-10. PubMed ID: 1850660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).
    Yam JW; Zheng JY; Hsiao WL
    Biochem Biophys Res Commun; 1999 Dec; 266(2):472-80. PubMed ID: 10600527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential effects of p53 mutants on the growth of human bronchial epithelial cells.
    Coursen JD; Bennett WP; Khan MA; Forrester K; Pietenpol JA; Harris CC
    Mol Carcinog; 1997 Jul; 19(3):191-203. PubMed ID: 9254886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression.
    Seewaldt VL; Dietze EC; Johnson BS; Collins SJ; Parker MB
    Cell Growth Differ; 1999 Jan; 10(1):49-59. PubMed ID: 9950218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 mutations in bladder carcinoma cell lines.
    Cooper MJ; Haluschak JJ; Johnson D; Schwartz S; Morrison LJ; Lippa M; Hatzivassiliou G; Tan J
    Oncol Res; 1994; 6(12):569-79. PubMed ID: 7787250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines.
    Li CY; Nagasawa H; Dahlberg WK; Little JB
    Oncogene; 1995 Nov; 11(9):1885-92. PubMed ID: 7478618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
    Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR
    Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
    Kessis TD; Slebos RJ; Nelson WG; Kastan MB; Plunkett BS; Han SM; Lorincz AT; Hedrick L; Cho KR
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3988-92. PubMed ID: 8387205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered expression of the tumor suppressor/oncoprotein p53 in SV40 Tag-transformed human placental trophoblast and malignant trophoblast cell lines.
    Aboagye-Mathiesen G; Zdravkovic M; Tóth FD; Graham CH; Lala PK; Ebbesen P
    Early Pregnancy; 1996 Jun; 2(2):102-12. PubMed ID: 9363207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx.
    Maestro R; Dolcetti R; Gasparotto D; Doglioni C; Pelucchi S; Barzan L; Grandi E; Boiocchi M
    Oncogene; 1992 Jun; 7(6):1159-66. PubMed ID: 1594246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.